+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enteric Disease Testing Market Size, Share & Trends Analysis Report By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893232
The global enteric disease testing market size is expected to reach USD 4.68 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied by unhygienic living conditions, and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate. Economic and environmental factors such as poor sanitation and the rising population living below the poverty line with no access to hygienic food and water supply are attributed to the growing incidence rate of the infections and thus propel the market growth.

According to the database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500, 000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 years of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Enteric Disease Testing Market Report Highlights

  • Bacterial enteric disease testing market segment dominated with the largest revenue share and is also expected to grow at the fastest CAGR during the forecast period from 2023 to 2030 due to a higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection-induced diarrhea.
  • The parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium, and E. histolytica.
  • Europe dominated the market with the largest revenue share of 39.0% in 2022, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 4.0% over the forecast period from 2023 to 2030. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in the detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other’s strengths and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced a collaboration with PeaceHealth to enhance the service through high-value design and innovation.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Disease type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Enteric Disease Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Enteric Disease Testing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Enteric Disease Testing Market: Disease Type Estimates & Trend Analysis
4.1. Enteric Disease Testing Market, Key Takeaways
4.2. Enteric Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Bacterial Enteric Disease
4.3.1. Bacterial enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Viral Enteric Disease
4.4.1. Viral enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Rotavirus
4.4.2.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Norovirus
4.4.3.1. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Parasitic Enteric Disease
4.5.1. Parasitic enteric disease market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Enteric Disease Testing Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Enteric Disease Testing Market by Region: Key Takeaway
5.3. North America
5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Sweden
5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Norway
5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. Saudi Arabia
5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. South Africa
5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Abbott
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. BD
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Biomerica
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. BIOMÉRIEUX
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Bio-Rad Laboratories, Inc.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Cepheid
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Coris BioConcept
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. DiaSorin S.p.A.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Meridian Bioscience
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Quest Diagnostics Incorporated
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 3 North America enteric disease testing market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 5 Canada enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 6 Europe enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 7 Europe enteric disease testing market, by region, 2018 - 2030 (USD Million)
Table 8 Germany enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 9 UK enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 10 France enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 11 Italy enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 12 Spain enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 13 Sweden enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 14 Norway enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 15 Denmark enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 17 Asia Pacific enteric disease testing market, by region, 2018 - 2030 (USD Million)
Table 18 Japan enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 19 China enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 20 India enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 21 Australia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 22 Thailand enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 23 South Korea enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 24 Latin America enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 25 Latin America enteric disease testing market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 27 Mexico enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 28 Argentina enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa enteric disease testing market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 33 UAE enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
Table 34 Kuwait enteric disease testing market, by disease type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Enteric disease testing: market outlook
Fig. 9 Enteric disease testing competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Enteric disease testing market driver impact
Fig. 15 Enteric disease testing market restraint impact
Fig. 16 Enteric disease testing market strategic initiatives analysis
Fig. 17 Enteric disease testing market: Disease type movement analysis
Fig. 18 Enteric disease testing market: Disease type outlook and key takeaways
Fig. 19 Bacterial enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Viral enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Rotavirus market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Norovirus market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Parasitic enteric disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Enteric disease testing market: Regional movement analysis
Fig. 25 Enteric disease testing market: Regional outlook and key takeaways
Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Abbott
  • BD
  • Biomerica
  • BIOMÉRIEUX
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Coris BioConcept
  • DiaSorin S.p.A.
  • Meridian Bioscience
  • Quest Diagnostics Incorporated

Methodology

Loading
LOADING...

Table Information